These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11185927)

  • 1. Magnetic resonance spectroscopy and schizophrenia: what have we learnt?
    Vance AL; Velakoulis D; Maruff P; Wood SJ; Desmond P; Pantelis C
    Aust N Z J Psychiatry; 2000 Feb; 34(1):14-25. PubMed ID: 11185927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
    O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
    Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders.
    Stanley JA
    Can J Psychiatry; 2002 May; 47(4):315-26. PubMed ID: 12025430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging volumetric and phosphorus 31 magnetic resonance spectroscopy measurements in schizophrenia.
    Hinsberger AD; Williamson PC; Carr TJ; Stanley JA; Drost DJ; Densmore M; MacFabe GC; Montemurro DG
    J Psychiatry Neurosci; 1997 Mar; 22(2):111-7. PubMed ID: 9074305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging and spectroscopy in schizophrenia.
    Waddington JL; O'Callaghan E; Larkin C; Redmond O; Stack J; Ennis JT
    Br J Psychiatry Suppl; 1990; (9):56-65. PubMed ID: 2291820
    [No Abstract]   [Full Text] [Related]  

  • 6. 31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia.
    Pettegrew JW; Keshavan MS; Minshew NJ
    Schizophr Bull; 1993; 19(1):35-53. PubMed ID: 8451612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders.
    Soares JC; Krishnan KR; Keshavan MS
    Depression; 1996; 4(1):14-30. PubMed ID: 9160650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia.
    Reddy R; Keshavan MS
    Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):401-5. PubMed ID: 14623493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Magnetic resonance spectroscopy in schizophrenia. Possibilities and limitations].
    Wobrock T; Scherk H; Falkai P
    Radiologe; 2005 Feb; 45(2):124-30, 132-6. PubMed ID: 15645203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance spectroscopy and its applications in psychiatry.
    Malhi GS; Valenzuela M; Wen W; Sachdev P
    Aust N Z J Psychiatry; 2002 Feb; 36(1):31-43. PubMed ID: 11929436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Magnetic resonance spectroscopy in schizophrenia].
    Delamillieure P; Constans JM; Fernandez J; Dollfus S
    Encephale; 2000; 26(1):21-31. PubMed ID: 10875059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo magnetic resonance spectroscopy. Applications in psychiatry.
    Maier M
    Br J Psychiatry; 1995 Sep; 167(3):299-306. PubMed ID: 7496637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla.
    Jensen JE; Miller J; Williamson PC; Neufeld RW; Menon RS; Malla A; Manchanda R; Schaefer B; Densmore M; Drost DJ
    Psychiatry Res; 2006 Mar; 146(2):127-35. PubMed ID: 16497488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia.
    Deicken RF; Zhou L; Schuff N; Weiner MW
    Schizophr Res; 1997 Oct; 27(1):65-71. PubMed ID: 9373896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy.
    Deicken RF; Zhou L; Schuff N; Fein G; Weiner MW
    Biol Psychiatry; 1998 Apr; 43(7):483-8. PubMed ID: 9547926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism.
    Duarte JMN; Xin L
    Neurochem Res; 2019 Jan; 44(1):102-116. PubMed ID: 29616444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorus magnetic resonance spectroscopy studies in schizophrenia.
    Yuksel C; Tegin C; O'Connor L; Du F; Ahat E; Cohen BM; Ongur D
    J Psychiatr Res; 2015 Sep; 68():157-66. PubMed ID: 26228415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.
    Yamasue H; Fukui T; Fukuda R; Kasai K; Iwanami A; Kato N; Kato T
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):353-60. PubMed ID: 14604450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance spectroscopy of brain in epilepsy.
    Ranjeva JP; Confort-Gouny S; Le Fur Y; Cozzone PJ
    Childs Nerv Syst; 2000 Apr; 16(4):235-41. PubMed ID: 10855522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.